Excipients are important part of the drug development process and ensure that the formulation remains stable throughout the development process as well when it is administered. It is basically any other component of the drug outside the medicinal component as it acts as a vehicle or a carrier for the medicinal product. This way stability to the formulation is provided. Wrong selection of excipient can lead to complications like intoxication of the patients. In ocular drugs, they play an important role in maintaining the tonicity, pH, stability, viscosity and sterility of the formulation.
The global Ocular Drug Excipient market was valued at US$ 863 million in 2023 and is anticipated to reach US$ 1302.5 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ocular Drug Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Drug Excipient.
Report Scope
The Ocular Drug Excipient market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ocular Drug Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ocular Drug Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BASF
Beneo
Evonik
Excipact
Fuji Chemical Industries
InVitria
Innophos
JRS Pharma
IOI Oleochemical
Millipore Sigma
Mallinckrodt Pharmaceuticals
Pfanstiehl
PerkinElmer
Natoli
DFE Pharma
Segment by Type
Organic Compounds
Inorganic Compounds
Segment by Application
Pharmaceutical Companies
Biopharmaceutical Companies
Contract Manufacturing Organizations (CMOs)
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ocular Drug Excipient manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Ocular Drug Excipient by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Ocular Drug Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Ocular Drug Excipient Market Overview
1.1 Product Definition
1.2 Ocular Drug Excipient Segment by Type
1.2.1 Global Ocular Drug Excipient Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Organic Compounds
1.2.3 Inorganic Compounds
1.3 Ocular Drug Excipient Segment by Application
1.3.1 Global Ocular Drug Excipient Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Manufacturing Organizations (CMOs)
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Ocular Drug Excipient Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Ocular Drug Excipient Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Ocular Drug Excipient Production Estimates and Forecasts (2019-2030)
1.4.4 Global Ocular Drug Excipient Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Ocular Drug Excipient Production Market Share by Manufacturers (2019-2024)
2.2 Global Ocular Drug Excipient Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Ocular Drug Excipient, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Ocular Drug Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Ocular Drug Excipient Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Ocular Drug Excipient, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Ocular Drug Excipient, Product Offered and Application
2.8 Global Key Manufacturers of Ocular Drug Excipient, Date of Enter into This Industry
2.9 Ocular Drug Excipient Market Competitive Situation and Trends
2.9.1 Ocular Drug Excipient Market Concentration Rate
2.9.2 Global 5 and 10 Largest Ocular Drug Excipient Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Ocular Drug Excipient Production by Region
3.1 Global Ocular Drug Excipient Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Ocular Drug Excipient Production Value by Region (2019-2030)
3.2.1 Global Ocular Drug Excipient Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Ocular Drug Excipient by Region (2025-2030)
3.3 Global Ocular Drug Excipient Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Ocular Drug Excipient Production by Region (2019-2030)
3.4.1 Global Ocular Drug Excipient Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Ocular Drug Excipient by Region (2025-2030)
3.5 Global Ocular Drug Excipient Market Price Analysis by Region (2019-2024)
3.6 Global Ocular Drug Excipient Production and Value, Year-over-Year Growth
3.6.1 North America Ocular Drug Excipient Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Ocular Drug Excipient Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Ocular Drug Excipient Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Ocular Drug Excipient Production Value Estimates and Forecasts (2019-2030)
4 Ocular Drug Excipient Consumption by Region
4.1 Global Ocular Drug Excipient Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Ocular Drug Excipient Consumption by Region (2019-2030)
4.2.1 Global Ocular Drug Excipient Consumption by Region (2019-2024)
4.2.2 Global Ocular Drug Excipient Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Ocular Drug Excipient Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Ocular Drug Excipient Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ocular Drug Excipient Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Ocular Drug Excipient Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ocular Drug Excipient Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Ocular Drug Excipient Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ocular Drug Excipient Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Ocular Drug Excipient Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Ocular Drug Excipient Production by Type (2019-2030)
5.1.1 Global Ocular Drug Excipient Production by Type (2019-2024)
5.1.2 Global Ocular Drug Excipient Production by Type (2025-2030)
5.1.3 Global Ocular Drug Excipient Production Market Share by Type (2019-2030)
5.2 Global Ocular Drug Excipient Production Value by Type (2019-2030)
5.2.1 Global Ocular Drug Excipient Production Value by Type (2019-2024)
5.2.2 Global Ocular Drug Excipient Production Value by Type (2025-2030)
5.2.3 Global Ocular Drug Excipient Production Value Market Share by Type (2019-2030)
5.3 Global Ocular Drug Excipient Price by Type (2019-2030)
6 Segment by Application
6.1 Global Ocular Drug Excipient Production by Application (2019-2030)
6.1.1 Global Ocular Drug Excipient Production by Application (2019-2024)
6.1.2 Global Ocular Drug Excipient Production by Application (2025-2030)
6.1.3 Global Ocular Drug Excipient Production Market Share by Application (2019-2030)
6.2 Global Ocular Drug Excipient Production Value by Application (2019-2030)
6.2.1 Global Ocular Drug Excipient Production Value by Application (2019-2024)
6.2.2 Global Ocular Drug Excipient Production Value by Application (2025-2030)
6.2.3 Global Ocular Drug Excipient Production Value Market Share by Application (2019-2030)
6.3 Global Ocular Drug Excipient Price by Application (2019-2030)
7 Key Companies Profiled
7.1 BASF
7.1.1 BASF Ocular Drug Excipient Corporation Information
7.1.2 BASF Ocular Drug Excipient Product Portfolio
7.1.3 BASF Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.1.4 BASF Main Business and Markets Served
7.1.5 BASF Recent Developments/Updates
7.2 Beneo
7.2.1 Beneo Ocular Drug Excipient Corporation Information
7.2.2 Beneo Ocular Drug Excipient Product Portfolio
7.2.3 Beneo Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Beneo Main Business and Markets Served
7.2.5 Beneo Recent Developments/Updates
7.3 Evonik
7.3.1 Evonik Ocular Drug Excipient Corporation Information
7.3.2 Evonik Ocular Drug Excipient Product Portfolio
7.3.3 Evonik Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Evonik Main Business and Markets Served
7.3.5 Evonik Recent Developments/Updates
7.4 Excipact
7.4.1 Excipact Ocular Drug Excipient Corporation Information
7.4.2 Excipact Ocular Drug Excipient Product Portfolio
7.4.3 Excipact Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Excipact Main Business and Markets Served
7.4.5 Excipact Recent Developments/Updates
7.5 Fuji Chemical Industries
7.5.1 Fuji Chemical Industries Ocular Drug Excipient Corporation Information
7.5.2 Fuji Chemical Industries Ocular Drug Excipient Product Portfolio
7.5.3 Fuji Chemical Industries Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Fuji Chemical Industries Main Business and Markets Served
7.5.5 Fuji Chemical Industries Recent Developments/Updates
7.6 InVitria
7.6.1 InVitria Ocular Drug Excipient Corporation Information
7.6.2 InVitria Ocular Drug Excipient Product Portfolio
7.6.3 InVitria Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.6.4 InVitria Main Business and Markets Served
7.6.5 InVitria Recent Developments/Updates
7.7 Innophos
7.7.1 Innophos Ocular Drug Excipient Corporation Information
7.7.2 Innophos Ocular Drug Excipient Product Portfolio
7.7.3 Innophos Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Innophos Main Business and Markets Served
7.7.5 Innophos Recent Developments/Updates
7.8 JRS Pharma
7.8.1 JRS Pharma Ocular Drug Excipient Corporation Information
7.8.2 JRS Pharma Ocular Drug Excipient Product Portfolio
7.8.3 JRS Pharma Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.8.4 JRS Pharma Main Business and Markets Served
7.7.5 JRS Pharma Recent Developments/Updates
7.9 IOI Oleochemical
7.9.1 IOI Oleochemical Ocular Drug Excipient Corporation Information
7.9.2 IOI Oleochemical Ocular Drug Excipient Product Portfolio
7.9.3 IOI Oleochemical Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.9.4 IOI Oleochemical Main Business and Markets Served
7.9.5 IOI Oleochemical Recent Developments/Updates
7.10 Millipore Sigma
7.10.1 Millipore Sigma Ocular Drug Excipient Corporation Information
7.10.2 Millipore Sigma Ocular Drug Excipient Product Portfolio
7.10.3 Millipore Sigma Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Millipore Sigma Main Business and Markets Served
7.10.5 Millipore Sigma Recent Developments/Updates
7.11 Mallinckrodt Pharmaceuticals
7.11.1 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Corporation Information
7.11.2 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Product Portfolio
7.11.3 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Mallinckrodt Pharmaceuticals Main Business and Markets Served
7.11.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.12 Pfanstiehl
7.12.1 Pfanstiehl Ocular Drug Excipient Corporation Information
7.12.2 Pfanstiehl Ocular Drug Excipient Product Portfolio
7.12.3 Pfanstiehl Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Pfanstiehl Main Business and Markets Served
7.12.5 Pfanstiehl Recent Developments/Updates
7.13 PerkinElmer
7.13.1 PerkinElmer Ocular Drug Excipient Corporation Information
7.13.2 PerkinElmer Ocular Drug Excipient Product Portfolio
7.13.3 PerkinElmer Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.13.4 PerkinElmer Main Business and Markets Served
7.13.5 PerkinElmer Recent Developments/Updates
7.14 Natoli
7.14.1 Natoli Ocular Drug Excipient Corporation Information
7.14.2 Natoli Ocular Drug Excipient Product Portfolio
7.14.3 Natoli Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Natoli Main Business and Markets Served
7.14.5 Natoli Recent Developments/Updates
7.15 DFE Pharma
7.15.1 DFE Pharma Ocular Drug Excipient Corporation Information
7.15.2 DFE Pharma Ocular Drug Excipient Product Portfolio
7.15.3 DFE Pharma Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.15.4 DFE Pharma Main Business and Markets Served
7.15.5 DFE Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Ocular Drug Excipient Industry Chain Analysis
8.2 Ocular Drug Excipient Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ocular Drug Excipient Production Mode & Process
8.4 Ocular Drug Excipient Sales and Marketing
8.4.1 Ocular Drug Excipient Sales Channels
8.4.2 Ocular Drug Excipient Distributors
8.5 Ocular Drug Excipient Customers
9 Ocular Drug Excipient Market Dynamics
9.1 Ocular Drug Excipient Industry Trends
9.2 Ocular Drug Excipient Market Drivers
9.3 Ocular Drug Excipient Market Challenges
9.4 Ocular Drug Excipient Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
BASF
Beneo
Evonik
Excipact
Fuji Chemical Industries
InVitria
Innophos
JRS Pharma
IOI Oleochemical
Millipore Sigma
Mallinckrodt Pharmaceuticals
Pfanstiehl
PerkinElmer
Natoli
DFE Pharma
听
听
*If Applicable.
